Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting
Sportradar Reports First Quarter 2026 Financial Results and Announces $250 Million Enhanced Open Market Share Repurchase Program
Incyte Reports First Quarter 2026 Financial Results and Provides Business Updates
Perfect Corp. Reports Unaudited Financial Results for the Three Months Ended March 31, 2026
Vestis Announces Date for Fiscal Second Quarter 2026 Results Conference Call and Webcast
Axogen, Inc. Reports First Quarter 2026 Financial Results
Stepan Reports First Quarter 2026 Results
CECO Environmental Reports First Quarter 2026 Results
Haleon Launches For the Assist Campaign in Partnership with the U.S. Soccer Federation Featuring Stars Tyler Adams and Crystal Dunn
The Sherwin-Williams Company Reports 2026 First Quarter Financial Results